의약품 관련 법령
Patient-Focused Drug Development: Collecting Comprehensive and Representative Input
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2018-07-31 | 조회수 | 650 |
국가정보 | 북 아메리카>미국 | ||
출처 | |||
원문 | https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM610442.pdf | ||
첨부파일 |
Patient-Focused Drug Development: Collecting Comprehensive and Representative Input
- 이전글 Medical Product Communications That Are Consistent With the FDA-Required Labeling — Questions and Answers Guidance for Industry
- 다음글 Limited Population Pathway for Antibacterial and Antifungal Drugs Guidance for Industry